BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32271410)

  • 61. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
    Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mitofusin-2 enhances cervical cancer progression through Wnt/β-catenin signaling.
    Ahn SY
    BMB Rep; 2024 Apr; 57(4):194-199. PubMed ID: 38449303
    [TBL] [Abstract][Full Text] [Related]  

  • 63. LncRNA H19 Promoted the Epithelial to Mesenchymal Transition and Metastasis in Gastric Cancer via Activating Wnt/β-Catenin Signaling.
    Liu J; Wang G; Zhao J; Liu X; Zhang K; Gong G; Pan H; Jiang Z
    Dig Dis; 2022; 40(4):436-447. PubMed ID: 34348271
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
    Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
    IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long non-coding RNA ENST00000434223 inhibits the progression of renal cancer through Wnt/hygro-catenin signaling pathway.
    Luo NQ; Ma DR; Yang XC; Liu Y; Zhou P; Guo LJ; Huang XD
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6868-6877. PubMed ID: 31486486
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
    Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Higher lncRNA CASC15 expression predicts poor prognosis and associates with tumor growth in cervical cancer.
    Shan S; Li HF; Yang XY; Guo S; Guo Y; Chu L; Xu MJ; Xin DM
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):507-512. PubMed ID: 30720157
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through β-catenin/c-Myc signaling pathway.
    Dai M; Song J; Wang L; Zhou K; Shu L
    J Bioenerg Biomembr; 2021 Oct; 53(5):597-608. PubMed ID: 34309767
    [TBL] [Abstract][Full Text] [Related]  

  • 70. LncROR Promotes Bladder Cancer Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition.
    Chen Y; Peng Y; Xu Z; Ge B; Xiang X; Zhang T; Gao L; Shi H; Wang C; Huang J
    Cell Physiol Biochem; 2017; 41(6):2399-2410. PubMed ID: 28463831
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MiR-638 inhibits cervical cancer metastasis through Wnt/β-catenin signaling pathway and correlates with prognosis of cervical cancer patients.
    Wei H; Zhang JJ; Tang QL
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5587-5593. PubMed ID: 29271990
    [TBL] [Abstract][Full Text] [Related]  

  • 72. FTO-stabilized lncRNA HOXC13-AS epigenetically upregulated FZD6 and activated Wnt/β-catenin signaling to drive cervical cancer proliferation, invasion, and EMT.
    Wang T; Li W; Ye B; Zhang S; Lei X; Zhang D
    J BUON; 2021; 26(4):1279-1291. PubMed ID: 34564982
    [TBL] [Abstract][Full Text] [Related]  

  • 73. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effect of LncRNA HOTAIR on the proliferation, apoptosis and drug resistance of Wilms tumor cells through Wnt/β-catenin signaling pathway].
    Yang LL; Cao GH; Liu YJ; Liu CH
    Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):769-774. PubMed ID: 34289571
    [No Abstract]   [Full Text] [Related]  

  • 75. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
    Ji Y; Wang M; Li X; Cui F
    Yonsei Med J; 2019 Apr; 60(4):336-345. PubMed ID: 30900419
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway.
    Park SA; Kim LK; Kim YT; Heo TH; Kim HJ
    Int J Biol Sci; 2020; 16(1):99-115. PubMed ID: 31892849
    [No Abstract]   [Full Text] [Related]  

  • 77. Up-regulation of long non-coding RNA SNHG1 contributes to proliferation and metastasis in laryngeal squamous cell carcinoma.
    Lin SX; Jiang H; Xiang GZ; Zhang WR; Weng YH; Qiu FD; Wu J; Wang HG
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1333-1341. PubMed ID: 29565491
    [TBL] [Abstract][Full Text] [Related]  

  • 78. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 79. TMEM48 promotes cell proliferation and invasion in cervical cancer via activation of the Wnt/β-catenin pathway.
    Jiang XY; Wang L; Liu ZY; Song WX; Zhou M; Xi L
    J Recept Signal Transduct Res; 2021 Aug; 41(4):371-377. PubMed ID: 32896205
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.